Latest Breaking News On - Sanitaria de santiago - Page 1 : comparemela.com

Results for GSK s RSV vaccine candidate published in New England Journal of Medicine

Results for GSK s RSV vaccine candidate published in New England Journal of Medicine
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Tony woodCenters for diseaseNew england journalDisease controlProfessor martinInstituto de investigaciSanitaria de santiago

GSK RSV older adult vaccine candidate publishes in New England Journal of Medicine

GSK RSV older adult vaccine candidate publishes in New England Journal of Medicine

Tony woodDrug administration vaccinesProducts advisory committeeNew england journalChief scientific officerVaccine clinical trials unitInstituto de investigaciSanitaria de santiagoDrug administrationRelated biological products advisory committeeBiologics license applicationAdult respiratory syncytial virus

Landmark New England Journal of Medicine publication reinforces potential of GSK s respiratory syncytial virus older adult vaccine candidate

GSK plc (LSE/NYSE: GSK) today announced the publication of positive phase III trial results for its respiratory syncytial virus (RSV) older adult vaccine candidate in the New England Journal of Medicine. The publication summarises the pivotal efficacy data (previously presented at IDWeek 2022), showing the vaccine .

Tony woodCompany annual report on formAntigenics incDrug administration vaccinesAgenus incProducts advisory committeeNew england journalChief scientific officerVaccine clinical trials unitInstituto de investigaciSanitaria de santiagoDrug administrationRelated biological products advisory committeeBiologics license applicationAdult respiratory syncytial virusAnnual report